Dermatologicals in Norway demonstrates resilient performance with a 3% rise in value to NOK1,070 million in 2026, reflecting sustained consumer reliance on essential treatments in a climate marked by slow but steady population growth and high digital literacy. Compared to other Western European countries, Norway’s demand is distinguished by its link to environmental conditions, such as a cold climate and active outdoor routines, and a demographic shift towards an older population, which together anchor the need for solutions to common skin concerns. The environment is highly attractive for established manufacturers due to a consolidated structure and a consumer base that consistently prioritises trust, efficacy, and clinical validation over novelty or price. Winning strategies include portfolio diversification, tailored communication to privacy-conscious shoppers, and incremental innovation focused on convenience and efficacy. Brands that successfully leverage digital content, enhance the online journey, and deepen loyalty through trusted pharmacy partnerships are best positioned to capture further gains as the migration to e-commerce continues.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Dermatologicals industry in Norway with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Dermatologicals industry in Norway, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Dermatologicals in Norway report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Dermatologicals in Norway?
- Which are the leading brands in Dermatologicals in Norway?
- How are products distributed in Dermatologicals in Norway?
- How has the regulatory and operating environment for Dermatologicals changed in Norway?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Dermatologicals
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Lamisil's tailored approach meets outdoor lifestyles and drives stable gains
Lamisil diversification and proactive hair loss treatment to anchor dermatologicals
Farmasiet's digital education and discreet e-commerce fuel online shift
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
E-commerce to accelerate discreet purchasing as brand trust drives repeat sales
Topical antifungals to sustain strength as hair loss treatments surge ahead
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Karo Healthcare strengthens lead as trusted brands deter switching
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies anchor trust while grocery retailers play a supporting role
Online pharmacies attract privacy-seeking shoppers with wider choice
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Dermatologicals
- Medicated Shampoos
- Topical Antifungals
- Vaginal Antifungals
- Hair Loss Treatments
- Nappy (Diaper) Rash Treatments
- Antiparasitics/Lice (Head and Body) Treatments
- Antipruritics
- Cold Sore Treatments
- Haemorrhoid Treatments
- Paediatric Dermatologicals
- Topical Allergy Remedies/Antihistamines
- Topical Germicidals/Antiseptics
Dermatologicals
Includes topical standard and herbal/traditional medicated products used to alleviate symptoms or treat skin or hair ailments. Exclude any systemic (oral) options to treat skin conditions or diseases.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Dermatologicals research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!